Derma Sciences losses widen, sales increase in Q3

Wed, 11/13/2013 - 3:33pm
Mass Device

Wound care company Derma Sciences posted a 12.7% boost in sales for its 3rd quarter, as well as a 62% increase in losses.

Derma Sciences lossed widen, sales increase in Q3

Derma Sciences (NSDQ:DSCI) got a little bit of attention from Wall Street today, with shares up a modest 0.6% in late afternoon trading following release of the company's Q3 earnings.

The New Jersey wound care company widened losses on a strong boost in sales during the 3 months ended September 30, with per-share losses well under analysts' consensus estimates.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.